Novacyt S.A. reiterates revenue guidance of £100 million for the full year 2021, excluding DHSC revenues, as announced on 22 June 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.831 EUR | +0.36% | +6.54% | +16.55% |
19/04 | Novacyt: confident ahead of DHSC trial | CF |
19/04 | Novacyt expects court to dismiss application by UK DHSC | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.55% | 62.59M | |
-29.76% | 924M | |
-19.12% | 130M | |
-7.98% | 68.37M | |
+6.78% | 60.11M | |
+1.80% | 52.22M |
- Stock Market
- Equities
- ALNOV Stock
- News Novacyt
- Novacyt S.A. Reiterate Revenue Guidance for the Full Year 2021